Paper · 41370732
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.
Goulart H and 27 others. JCO Precis Oncol, 2025. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia. Papers, record 41370732. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41370732
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Biphenotypic, Acute | Major topic |
| Humans | |
| Male | |
| Female | |
| Aged | |
| Middle Aged | |
| Retrospective Studies | |
| Adult | |
| Aged, 80 and over | |
| Treatment Outcome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed and NIH | NIH RePORTER |
| P50 CA100632 | NCI NIH HHS | United States | P50CA100632 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,797,463 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. | Blood | 2022 | https://conductscience.org/library/papers/35797463 | PubMed |
| 2 | 21,266,800 | Clinical characteristics, biological profile, and outcome of biphenotypic acute leukemia: a case series. | Acta Haematol | 2011 | https://conductscience.org/library/papers/21266800 | PubMed |
| 3 | 7,564,526 | Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). | Leukemia | 1995 | https://conductscience.org/library/papers/7564526 | PubMed |
| 4 | 25,605,373 | How I treat mixed-phenotype acute leukemia. | Blood | 2015 | https://conductscience.org/library/papers/25605373 | PubMed |
| 5 | 29,550,836 | Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis. | Leukemia | 2018 | https://conductscience.org/library/papers/29550836 | PubMed |
| 6 | 2,031,964 | A classification of acute leukaemia for the 1990s. | Ann Hematol | 1991 | https://conductscience.org/library/papers/2031964 | PubMed |
| 7 | 40,105,906 | Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges. | Cancer | 2025 | https://conductscience.org/library/papers/40105906 | PubMed |
| 8 | 27,069,254 | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. | Blood | 2016 | https://conductscience.org/library/papers/27069254 | PubMed |
| 9 | 24,146,232 | Diagnosing and treating mixed phenotype acute leukemia: a multicenter 10-year experience in México. | Ann Hematol | 2014 | https://conductscience.org/library/papers/24146232 | PubMed |
| 10 | 33,618,432 | Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia. | Br J Haematol | 2021 | https://conductscience.org/library/papers/33618432 | PubMed |
1 to 10 of 23
See all 23 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,867,742 | Venetoclax combined with olverembatinib and prednisone as a frontline therapeutic strategy for Philadelphia chromosome-positive mixed-phenotype acute leukemia. | Blood Res | 2026 | https://conductscience.org/library/papers/42867742 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TP53 | 7,157 | PubTator's text mining | https://conductscience.org/library/genes/7157 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41370732
GET https://conductscience.org/api/papers/v1/41370732/authors?page=2